Noninterchangeability of Serum-Free Light Chain Assays at IMWG Thresholds: Analysis of 2117 Paired Samples
Clinical Lymphoma Myeloma and Leukemia · 2026-11 · 26 (11) · e1329-e1337
DOI: 10.1016/j.clml.2026.08.011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2026-11. Verfasst von Asmi Chattaraj und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Cellular Therapy, AHN Cancer Institute, Allegheny Health Network, Pittsburgh, PA. Electronic address: asmichattaraj@gmail.…. Hauptthemen laut MEDLINE: Multiple Myeloma, Immunoglobulin Light Chains. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The International Myeloma Working Group (IMWG) 2014 criteria define multiple myeloma (MM) by the presence of an involved/uninvolved serum-free light chain (sFLC) ratio ≥100, provided that the involved sFLC concentration is ≥100 mg/L, validated exclusively with the polyclonal Binding Site Freelite assay. The monoclonal Siemens N Latex FLC assay is increasingly used clinically, but analytical differences may affect disease classification. Additionally, κ:λ ratio thresholds of >20 and >8 identify high-risk smoldering MM (SMM) and predict progression in SMM and light chain monoclonal gammopathy of undetermined significance, respectively. PATIENTS AND METHODS: We retrospectively analyzed 2117 patients with MM or SMM who underwent paired sFLC testing on both platforms (Optilite and BN II) between December 2023 and February 2024. Analytical correlation, agreement, and bias were assessed using Spearman correlation, Passing-Bablok regression, Bland-Altman analysis, and kappa statistics at clinically relevant thresholds. RESULTS: Strong correlation was observed for free κ (r = 0.83) and free λ (r = 0.70), but Passing-Bablok regression revealed systematic proportional bias. At the IMWG myeloma-defining threshold (κ:λ ≥ 100), agreement was high (κ = 0.82), but discordant classifications occurred, with 4 patients classified as MM only by Optilite and 6 only by BN II. Agreement was substantial at κ:λ > 20 (κ = 0.74) and > 8 (κ = 0.74). CONCLUSION: Despite strong analytical correlation, systematic proportional bias produced clinically meaningful discordance at IMWG diagnostic thresholds. IMWG criteria validated using Freelite should not be directly extrapolated to Siemens N Latex results without assay-specific validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology and Cellular Therapy, AHN Cancer Institute, Allegheny Health Network, Pittsburgh, PA. Electronic address: asmichattaraj@gmail.com.
- Allegheny Health Network Research Institute, Allegheny Health Network, Pittsburgh, PA.
- Division of Hematology and Cellular Therapy, AHN Cancer Institute, Allegheny Health Network, Pittsburgh, PA.
- Department of Pathology, Allegheny Helath Network, Pittsburgh, PA.
- Levine Cancer Center, Atrium Health, Wake Forest University School of Medicine, Charlotte, NC.
- Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS.
Zitieren
APA
Chattaraj, A., Yin, Y., Babu, K., Rajarajan, S., Sadashiv, S., Lakshman, A., Trull, Y., Atrash, S., Abdallah, A. O., & Mewawalla, P. (2026). Noninterchangeability of Serum-Free Light Chain Assays at IMWG Thresholds: Analysis of 2117 Paired Samples. Clinical Lymphoma Myeloma and Leukemia, 26(11), e1329-e1337. https://doi.org/10.1016/j.clml.2026.08.011
Vancouver
Chattaraj A, Yin Y, Babu K, Rajarajan S, Sadashiv S, Lakshman A, et al. Noninterchangeability of Serum-Free Light Chain Assays at IMWG Thresholds: Analysis of 2117 Paired Samples. Clinical Lymphoma Myeloma and Leukemia. 2026;26(11):e1329-e1337. doi:10.1016/j.clml.2026.08.011
BibTeX
@article{Chattaraj2026,
author = {Chattaraj, Asmi and Yin, Yue and Babu, Kalaivani and Rajarajan, Srinishant and Sadashiv, Santhosh and Lakshman, Arjun and Trull, Yun and Atrash, Shebli and Abdallah, Al-Ola and Mewawalla, Prerna},
title = {Noninterchangeability of Serum-Free Light Chain Assays at IMWG Thresholds: Analysis of 2117 Paired Samples},
journal = {Clinical Lymphoma Myeloma and Leukemia},
year = {2026},
volume = {26},
number = {11},
pages = {e1329--e1337},
doi = {10.1016/j.clml.2026.08.011}
}
EUVIMED